Latest Investor Presentations News

First Graphene Limited reveals significant progress in commercialising its PureGRAPH graphene technology, highlighting expanding global partnerships and a robust sales pipeline valued over A$10 million.

Visionflex Group Limited reported a sharp 33% decline in revenues and a 69% increase in net losses for FY25, with auditors flagging material uncertainty over the company’s ability to continue as a going concern.

Qantas Airways has announced a fully franked dividend of AUD 0.264 per share for the first half of FY25, reflecting confidence in its financial position amid ongoing industry recovery.

ClearView Wealth Limited reported a solid 10% revenue increase for FY25 alongside a 126% jump in profit from continuing operations, yet net profit was tempered by losses from discontinued segments. The company paused its share buy-back program, signaling cautious capital management ahead.

InvestSMART Group has showcased its position as Australia’s leading direct-to-investor digital wealth platform, reporting $711 million in funds under management and highlighting its integrated ecosystem of low-cost funds, research, and tools.

Wisr Limited’s FY2025 results reveal a modest revenue decline alongside increased losses, with no dividends declared, highlighting ongoing challenges for the fintech lender.

Intelligent Monitoring Group reports robust FY2025 financials, completes a strategic acquisition, and issues new shares following warrant exercises, signaling a confident growth trajectory.

Tourism Holdings Limited reported a modest 2% revenue increase to NZD 937.2 million for the year ending June 2025, yet posted a significant net loss of NZD 25.8 million. Despite the losses, the company declared a final dividend, signaling cautious confidence.

Santos Limited delays its half-year results amid ongoing acquisition discussions with the XRG Consortium, which faces a four-week wait for final approvals before a binding deal can be signed.

AdAlta Limited outlines its innovative 'East to West' cellular immunotherapy approach, in-licensing Asian CAR-T assets and progressing clinical trials in Australia to unlock value. The company also seeks partners for its anti-fibrotic and anti-malarial protein therapeutics.

ClearVue Technologies has responded to ASX concerns after its CEO described previous project pipeline announcements as ‘fairy tales,’ affirming prior disclosures were accurate despite some project setbacks.

Pacgold Limited advances its Northern Queensland footprint with a maiden 900,000-ounce gold resource at Alice River and a new high-grade antimony acquisition at St George, positioning itself amid critical mineral supply challenges.